AbbVie stock edges higher as Berenberg lifts target; tariffs and Feb. 4 earnings in play
New York, January 21, 2026, 12:40 EST — Regular session AbbVie Inc shares were up 88 cents, or about 0.4%, at $214.92 in midday trading on Wednesday, a muted move after a fresh round of analyst target changes. The stock has traded between $211.92 and $218.00, with about 5.3 million shares changing hands. It matters now because drugmakers are heading…